The table below shows Coya Therapeutics, Inc.'s income statement line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Revenue
$7.95M
$3.55M
$6.00M
$0.00
-
Cost of revenue
-
-
-
-
-
Gross profit
-
-
-
-
-
R&D
-
-
-
-
-
SG&A
$11.45M
$8.89M
$7.83M
$4.85M
$2.31M
COYA annual revenue (10-K history)
Coya Therapeutics, Inc. reported annual revenue of $7.95M for fiscal year 2025. That is up 123.6% from $3.55M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.